Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07311369) titled 'Evaluate the Safety and Efficacy of HL-1186 Tablet for Postoperative Pain Management in Abdominal Surgery' on Dec. 16, 2025.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.

Condition: Moderate to Severe Acute Postoperative Pain

Intervention: Drug: HL-1186

Recruitment Status: Recruiting

Phase: Phase 2

Date of First Enrollment: December 2025

Target Sample Size: ...